Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer

IF 3 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

PET Clinics Pub Date : 2023-07-01 DOI:10.1016/j.cpet.2023.02.009

Tadashi Watabe MD, PhD , Frederik L. Giesel MD, MBA

引用次数: 1

查看原文本刊更多论文

胃癌成纤维细胞活化蛋白抑制剂的PET/CT研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

PET Clinics RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

CiteScore

5.70

自引率

3.80%

发文量

期刊介绍： As the clinical applications of positron emission tomography (PET) increase, the new PET Clinics brings together the combined expertise of leading authorities in the field to provide you incisive clinical reviews on advances in the use of PET and combined PET/CT. Published quarterly, PET Clinics provides concise, practical guidance on the clinical issues you face every day. It examines PET is effectiveness in cancer diagnosis and staging, as well as exploring PET is usefulness in the areas of dementia, myocardial viability, and other conditions. Full-color images featured throughout. Topics covered include Breast Cancer, Alzheimer is Disease and Dementia, Lymphoma, Lung Cancer, Cardiology, Pediatric Applications, Infection and Inflammation.

文献相关原料

公司名称	产品信息	采购帮参考价格